3902 Medical Data Vision Co.,Ltd. - Financial Results

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

3902

TSE Prime

Medical Data Vision Co.,Ltd.

370

JPY

-5

(-1.33%)

Dec 23, 3:30 pm JST

2.36

USD

Dec 23, 1:30 am EST

Result

PTS

outside of trading hours

ー

Summary Chart Historical News Financial Result

Current Period Guidance

Annual

Result

Guidance History

Growth Rate

Profitability

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Dec, 2020	4,579	1,146	1,148	700	17.7	3.60	Feb 8, 2021	J-GAAP
Dec, 2021	5,672	1,594	1,592	1,087	27.7	5.60	Feb 14, 2022	J-GAAP
Dec, 2022	6,104	1,758	1,750	870	22.8	6	Feb 13, 2023	J-GAAP
Dec, 2023	6,419	1,770	1,700	979	25.6	6.50	Feb 13, 2024	J-GAAP
Dec, 2024 Guidance	6,600	510	390	180	4.8	6.50	Nov 11, 2024	J-GAAP
YoY	+2.8%	-71.2%	-77.1%	-81.6%	-81.5%

Revision Direction	Revision Date	Revenue	Operating Profit	Ordinary Profit	Net Profit	Revised Dividend	Accounting Standards
Dec, 2019	Feb 12, 2019	4,250	500	500	279	0	J-GAAP
	Nov 11, 2019	3,840	650	650	400	0	J-GAAP
	Feb 6, 2020	4,026	809	804	554	0	J-GAAP
Results	Feb 10, 2020	4,026	809	804	554	0	J-GAAP
Dec, 2020	Feb 10, 2020	Available in future release
Results	Feb 8, 2021
Dec, 2021	Feb 8, 2021
	Aug 10, 2021
Results	Feb 14, 2022
Dec, 2022	Feb 14, 2022
Results	Feb 13, 2023
Dec, 2023	Feb 13, 2023
Results	Feb 13, 2024
Dec, 2024	Feb 13, 2024	8,000	1,630	1,540	1,000	6.5	J-GAAP
	Nov 11, 2024	6,600	510	390	180	6.5	J-GAAP

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Dec, 2009	841	－	Available in future release
Dec, 2010	1,063	+26.4
Dec, 2011	971	-8.7
Dec, 2012	1,167	+20.2
Dec, 2013	1,530	+31.1
Dec, 2014	1,950	+27.5
Dec, 2015	2,413	+23.7
Dec, 2016	2,632	+9.1
Dec, 2017	3,225	+22.5
Dec, 2018	3,577	+10.9
Dec, 2019	4,026	+12.6
Dec, 2020	4,579	+13.7
Dec, 2021	5,672	+23.9
Dec, 2022	6,104	+7.6
Dec, 2023	6,419	+5.2
Dec, 2024 Guidance	6,600	+2.8	510	-71.2	390	-77.1	4.8	-81.3

Fiscal Year	Revenue	Operating Profit	Operating Profit Margin	ROE	ROA	Total Asset Turnover Ratio	Adj. EPS
Dec, 2022	6,104	1,758	28.8	22.68	16.68	1.17	22.8
Dec, 2023	6,419	1,770	27.6	25.23	17.61	1.15	25.6
Dec, 2024 Guidance	6,600	510	7.73	4.84	3.44	1.26	4.8

All-Time High

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	6,419	1,770	1,750	1,087	27.7
Fiscal Year	Dec, 2023	Dec, 2023	Dec, 2022	Dec, 2021	Dec, 2021

Second Half

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Jul - Dec, 2021	3,037	874	873	603	15.4	5.60	Feb 14, 2022	J-GAAP
Jul - Dec, 2022	3,248	974	975	349	9.1	6	Feb 13, 2023	J-GAAP
Jul - Dec, 2023	3,417	1,051	1,000	534	14.0	6.50	Feb 13, 2024	J-GAAP
Jul - Dec, 2024 Guidance	3,820	484	422	266	7.0	6.50	Nov 11, 2024	J-GAAP
YoY	+11.8%	-53.9%	-57.8%	-50.2%	-49.8%

Cash Flow

Annual

Fiscal Year	Operating Profit	Fee Cash Flow	Operating Cash Flow	Investing Cash Flow	Financial Cash Flow	Cash & Equivalents	Cash Ratio	Accounting Standards
Dec, 2021	1,594	1,056	1,082	-26	-1,030	3,202	57.86	J-GAAP
Dec, 2022	1,758	42	910	-868	-979	2,264	46.23	J-GAAP
Dec, 2023	1,770	1,179	1,616	-437	-225	3,218	51.73	J-GAAP

Actual Performance and Financial Trends

Accumulated Results 3rd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Jan - Sep, 2022	4,327	1,165	1,156	775	20.3	66.1	Nov 14, 2022	J-GAAP
Jan - Sep, 2023	4,487	1,111	1,063	659	17.3	62.5	Nov 13, 2023	J-GAAP
Jan - Sep, 2024	4,125	-140	-229	-314	-8.2	ー	Nov 11, 2024	J-GAAP
YoY	-8.1%	－	－	－	－

Quarterly Results

Result

Growth Rate

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Oct - Dec, 2022	1,777	593	594	95	2.5	33.4	Feb 13, 2023	J-GAAP
Jan - Mar, 2023	1,559	423	424	275	7.2	27.1	May 11, 2023	J-GAAP
Apr - Jun, 2023	1,443	296	276	170	4.5	20.5	Aug 10, 2023	J-GAAP
Jul - Sep, 2023	1,485	392	363	214	5.6	26.4	Nov 13, 2023	J-GAAP
Oct - Dec, 2023	1,932	659	637	320	8.4	34.1	Feb 13, 2024	J-GAAP
Jan - Mar, 2024	1,388	53	22	-15	-0.4	3.8	May 13, 2024	J-GAAP
Apr - Jun, 2024	1,392	-27	-54	-71	-1.9	-1.9	Aug 8, 2024	J-GAAP
Jul - Sep, 2024	1,345	-166	-197	-228	-6.0	-12.3	Nov 11, 2024	J-GAAP
YoY	-9.4%	－	－	－	－

Fiscal Year	Revenue	YoY	Operating Profit	YoY	Ordinary Profit	YoY	Adj. EPS	YoY
Oct - Dec, 2019	1,269	+8.1	Available in future release
Jan - Mar, 2020	1,042	+19.9
Apr - Jun, 2020	1,004	+9.5
Jul - Sep, 2020	1,107	+14.0
Oct - Dec, 2020	1,426	+12.4
Jan - Mar, 2021	1,429	+37.1
Apr - Jun, 2021	1,206	+20.1
Jul - Sep, 2021	1,317	+19.0
Oct - Dec, 2021	1,720	+20.6
Jan - Mar, 2022	1,511	+5.7
Apr - Jun, 2022	1,345	+11.5
Jul - Sep, 2022	1,471	+11.7
Oct - Dec, 2022	1,777	+3.3
Jan - Mar, 2023	1,559	+3.2
Apr - Jun, 2023	1,443	+7.3
Jul - Sep, 2023	1,485	+1.0
Oct - Dec, 2023	1,932	+8.7
Jan - Mar, 2024	1,388	-11.0
Apr - Jun, 2024	1,392	-3.5
Jul - Sep, 2024	1,345	-9.4	-166	－	-197	－	-6.0	－

All-Time High Quarterly Results

	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS
Record	1,932	659	637	388	9.9
Fiscal Year	Dec, 2023	Dec, 2023	Dec, 2023	Dec, 2021	Dec, 2021

Key Balance Sheet Figures

Fiscal Year	BPS	Equity Ratio	Total Asset	Equity	Retained Earnings	Interest-Bearing Debt Ratio	Announce	Accounting Standards
Dec, 2021	106.69	75.1	5,534	4,156	2,879	ー	Feb 14, 2022	J-GAAP
Dec, 2022	92.04	71.8	4,897	3,515	3,045	ー	Feb 13, 2023	J-GAAP
Dec, 2023	111.21	68.3	6,221	4,247	3,795	ー	Feb 13, 2024	J-GAAP
Jan - Sep, 2024	ー	71.2	5,228	3,721	3,232	ー	Nov 11, 2024	J-GAAP

Medical Data Vision Co.,Ltd.(3902) Financial Results